Grants and Contributions:
Title:
Onternabez, a Novel Therapeutic for Systemic Hyperinflammation
Agreement Number:
999631
Agreement Value:
$149,180.00
Agreement Date:
Jan 3, 2023 - Jul 3, 2023
Description:
National Research Council of Canada (NRC) is seeking potential therapeutics (ideally sub-micromolar potent) to treat respiratory disease by targeting viral infection, replication and/or address associated co-morbidities.
Organization:
National Research Council Canada
Expected Results:
Grow Canadian companies through direct funding to support early stage, pre-commercial research and development, late stage prototypes, and to accelerate commercialization.
Location:
Orleans, Ontario, CA K1C 1E8
Reference Number:
172-2022-2023-Q3-999631
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Business Number:
848009387
Recipient Type:
For-profit organization
Recipient's Legal Name:
Tetra Bio-Pharma Inc.
Research Organization:
National Research Council Canada/Conseil national de recherches Canada
Federal Riding Name:
Orléans
Federal Riding Number:
35076
Program:
Innovative Solutions Canada
Program Purpose:
Fuel the development and adoption of technological innovation in Canada
Coverage:
• Support the scale up and growth of Canada's innovators and entrepreneurs by having the federal government act as a first customer. • Stimuler l'expansion et la croissance des innovateurs et entrepreneurs canadiens en faisant du gouvernement fédéral le premier client des innovations canadiennes.